Laguilles, Aldwin C.

HRN: 21-32-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/14/2022
05/20/2022
TOPICAL
25gm
BID
Infected Wound Nasal Area
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: